latest news releases from the newsroom
Transmeridian Exploration, Inc.
Transmeridian Exploration Agrees to Purchase Bramex Management, Inc.
HOUSTON, Oct. 20, 2005 (PRIMEZONE) -- Transmeridian Exploration Incorporated (AMEX:TMY) today announced that it has agreed to purchase Bramex Management, Inc., which owns the 50% of JSC CaspiNeft TME not currently owned by Transmeridian. Transmeridian operates the South Alibek Field in Kazakhstan through its present interest in CaspiNeft under a joint operating agreement with Bramex. Upon the closing of the transaction, which is expected to occur on or about December 23, 2005, Transmeridian will own 100% of CaspiNeft. Closing of the transaction is subject to several conditions, including release of liens on the shares and assets of CaspiNeft, receipt of appropriate government approvals and other customary conditions.
Radiant Logistics, Inc.
Golf Two Completes Change Of Control Transaction
PHILADELPHIA, Oct. 20, 2005 (PRIMEZONE) -- Golf Two, Inc. (the "Company"), a development stage company initially formed to establish and operate retail golf stores, today announced that it completed a change of control transaction with a new management team, consisting of Bohn H. Crain and Stephen M. Cohen, acquiring 67.9% of the Company's outstanding securities in privately negotiated purchases from the former officers and directors.
BetUS.com Says Allen Iverson Most Likely to be Fined Most for Dress Code Violations
MONTREAL, Oct. 20, 2005 (PRIMEZONE) -- With the new NBA dress code set to begin in a few weeks, BetUS.com, an online gambling client endorsed by former Minnesota Governor Jesse Ventura, announced today the odds on who will be the player to be fined the most for violating the code. The code's most vocal critic, Allen Iverson, was named the favorite with 5 to 2 odds.
Amersin Life Sciences Corp.
Amersin Enters Into Termination Agreement With Chinese Joint Venture Partner
NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLSE) announced today that it has reached a termination agreement and will be disposing of its interest in the Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. joint venture in the Hubei Province of China. Under the terms of the agreement Amersin will return its interest in the joint venture to Benda Science and Technology Company in exchange for $220,000 to be paid within six months and the return of 1.6 million shares of Amersin common stock to treasury. Additional details may be found on Form 8-K filed with the Securities and Exchange Commission this date.
Discovery Laboratories, Inc.
Discovery Labs Surfaxin Licensed in Italy by Dompe Farmaceutici
WARRINGTON, Pa., Oct. 20, 2005 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced today that its development and marketing partner in Southern Europe, Laboratorios del Dr. Esteve, S.A. (Esteve) has sublicensed the distribution rights to Surfaxin(r) in Italy to Dompe Farmaceutici Spa (Dompe), a privately owned Italian company. Under this agreement Dompe will be responsible for sales, marketing and distribution in Italy of Surfaxin for the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants.
Paragon Real Estate Equity and Investment Trust
Paragon Files Form 8-K for Bylaw Amendment
CLEVELAND, Oct. 20, 2005 (PRIMEZONE) -- Paragon Real Estate Equity and Investment Trust (AMEX:PRG) filed with the Securities and Exchange Commission a current report on Form 8-K for an amendment to its bylaws that the board of trustees approved at a recent meeting to allow Paragon to issue its shares without a physical certificate. The amendment is in accordance with Maryland General Corporation Law Section 8-203. This change does not affect shares already in certificate form until they are surrendered to Paragon's stock transfer agent.
Five Sparrows LLC
MIR Preclinical Services Highlights Imaging Technologies at Major U.S. Exhibits in November, 2005
ANN ARBOR, Mich., Oct. 20, 2005 (PRIMEZONE) -- MIR Preclinical Services (MIR) is pleased to announce that it will be highlighting its high resolution small animal PET, preclinical MRI, in vivo micro-CT, and in vivo bioluminescence and fluorescence imaging technologies at two major conference exhibits in November. The first exhibit will be at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS), November 7-9 in Nashville, TN. The second exhibit will be at the 17th annual EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics", November 15-17 in Philadelphia, PA. These technologies are described below:
Nord Resources Corporation
Nord Resources Updates Activities
DRAGOON, Ariz., Oct. 20, 2005 (PRIMEZONE) -- Nord Resources Corporation (Pink Sheets:NRDS) is pleased to announce that it has recently completed a mezzanine financing in the amount of $2.85 million with a private firm. The proceeds from the mezzanine financing will replace an existing, outstanding debt facility which would have matured and become due on October 19, 2005.